JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 4 No. 11, November 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Does Antihypertensive Treatment of the Elderly Prevent Cardiovascular Events or Prolong Life?

A Meta-analysis of Hypertension Treatment Trials

Kevin A. Pearce, MD, MPH; Curt D. Furberg, MD, PhD; Julia Rushing, MStat

Arch Fam Med. 1995;4(11):943-949.


Abstract

Objective
To estimate the short-term effects of drug treatment of hypertension in the elderly (>=60 years of age) on stroke, major coronary events, and mortality rates.

Design
Meta-analysis of all published randomized, controlled trials that addressed the impact of drug treatment of hypertension in the elderly on the above outcomes.

Setting and Patients
All published clinical trials that met the above criteria involved men and women recruited from primary care practices or through community screenings, who were then treated according to protocol at either community or specialty clinics. Eight randomized, controlled trials that included 15 990 patients treated for an average of 4.6 years were included in this meta-analysis.

Interventions
Patients received either active antihypertensive treatment or placebo in seven of the studies and programmed stepped care vs referral back to the usual care source in one study.

Main Outcome Measures
Fatal or nonfatal myocardial infarction or sudden coronary death; fatal or nonfatal stroke; and all-cause mortality. Outcomes were analyzed on an intention-to-treat basis.

Results
Mean baseline blood pressure was 179/90 mm Hg, with a mean treatment effect of 15/6 mm Hg. Homogeneity tests indicated validity of the combined results. Pooled relative risks, calculated as treatment or control (with 95% confidence intervals) for the main end points, were as follows: fatal or nonfatal major coronary event, 0.82 (0.73 to 0.92); fatal or nonfatal stroke, 0.65 (0.57 to 0.75); and death from any cause, 0.85 (0.78 to 0.92) (P<.005 for each).

Conclusion
Antihypertensive treatment in the elderly prevents major coronary events and stroke and prolongs life, with significant treatment effects observed within only 5 years.



Author Affiliations

From the Departments of Family and Community Medicine (Dr Pearce) and Public Health Sciences (Dr Furberg and Ms Rushing), The Bowman Gray School of Medicine, Winston-Salem, NC.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The evolving science of translating research evidence into clinical practice
Scott
Evid. Based Med. 2007;12:4-7.
FULL TEXT  

Evaluating evidence-based practice performance
Alper and Vinson
Evid. Based Med. 2006;11:166-166.
FULL TEXT  

Heart Rate Adjustment of Exercise-Induced ST-Segment Depression Identifies Men Who Benefit From a Risk Factor Reduction Program
Okin et al.
Circulation 1997;96:2899-2904.
ABSTRACT | FULL TEXT  

Treating hypertension: the evidence from clinical trials
Simon
BMJ 1996;313:437-438.
FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.